Latest Tariffs News

AoFrio’s nine-month revenue fell 20% to NZ$50.3 million as motor sales plunged, while EBITDA dropped to NZ$0.8 million. The NZX-listed refrigeration technology company is relying on new US bottler orders, Food Retail expansion and its IoT platform to support a more profitable 2027.

Electrovaya will invest approximately A$2.0 million in Janus Electric through a proposed placement, while Janus has placed initial battery orders worth about A$37.5 million for its North American truck programme. The investment remains subject to completion conditions, and the battery orders depend on agreed delivery schedules.

Barramundi’s portfolio returned 3.0% on a gross basis in the September quarter, ahead of the ASX 200’s 1.3% gain. CSL, Ansell, MAAS Group and PWR Holdings led the recovery, although the NZX-listed investment company still traded at a 17.2% discount to NAV.

Botanix’s Sofdra prescriptions rose 5.3% in the September quarter, but flat net revenue and a sharp cash decline have forced a major reset. The company is targeting a roughly 50% reduction in operating expenses while assessing licensing, acquisitions and broader strategic transactions.

DataDot Technology Limited (ASX:DDT) delivered a stronger FY26, with revenue rising 14.1% to $3.85 million and profit before tax nearly tripling to $327,420. The sharper result was driven largely by PropertyVAULT’s first full year of insurance services, although key insurer relationships remain pilots or works in progress.

APA Group has committed a further $700 million to the Bulloo Interlink Pipeline after securing a five-year, take-or-pay agreement with Origin Energy. The 800 TJ/day project is aimed at easing projected north-to-south gas constraints, with construction targeted for early 2027 and operations for winter 2029.

Laserbond delivered strong FY26 growth despite higher tungsten costs and soft mining demand, while securing a second Komatsu licensing agreement and a new international collaboration with Metal 7. The company is now positioning lower-tungsten products, new coatings and expanded capacity for a much larger market.

Ramsay Health Care’s proposed separation of its 52.79% Ramsay Santé stake has reached a key regulatory milestone, with ASIC registering the Demerger Booklet. Shareholders will vote on the transaction on 24 November, but approval remains only one step in a process that could create two separately traded healthcare exposures.

NOVONIX has replaced a binding PowerCo supply agreement covering at least 32,000 tonnes of synthetic graphite with a framework that leaves volume and price unresolved. A new offtake deal will only be negotiated after customer qualification and further certification.

ARB Corporation’s FY26 profit fell 5.2% as weaker Australian aftermarket and OEM sales outweighed modest export growth. The 4x4 accessories maker is relying on improved vehicle supply, US expansion and new product programs to rebuild momentum in FY27.

Orora says strong Cans growth is no longer enough to offset weaker Saverglass earnings, with Group EBIT expected to decline in FY27. The company is targeting more than €30 million in Glass EBIT improvement by FY30 after a €449.7 million non-cash impairment.

Bubs Australia delivered 9.2% revenue growth and a sharp underlying EBITDA improvement in FY26, but statutory losses, weaker margins and negative operating cash flow expose the cost of its expansion. Permanent US FDA authorisation removes a major regulatory hurdle, while the annual report still flags material uncertainty around ongoing funding and cash generation.